🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03963349
Active, not recruiting Observational

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study

NCT03963349 · tracked via the Priya Life Science China tracker
Sponsor
Biosense Webster, Inc.
Phase
Observational
Started
2019-06-24
Last updated
2026-08-28

Condition(s) studied

Paroxysmal Atrial Fibrillation

Study summary

A single-center, real word study of consecutive subjects who undergo radiofrequency ablation for paroxysmal AF using THERMOCOOL SMARTTOUCH®SF (STSF) Catheter guiding by Ablation Index (AI). Prospectively or retrospectively record 150 eligible subjects since 1st Jan 2019 to evaluate effectiveness and safety of STSF with AI.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age 18 years or older 2. Patient has PAF eligible for AI-guided catheter ablation with an STSF catheter per standard of care assessment 3. Able and willing to comply with all pre-, post- and follow-up testing and requirements 4. Able to sign EC-approved informed consent form Exclusion Criteria: 1. AF is secondary to electrolyte imbalance, thyroid disease, or a reversible or non-cardiac cause 2. Patient has AF episodes lasting longer than 7 days 3. History of heart surgery, or any previous ablation for AF 4. Myocardial infarction (MI), coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) within preceding 3 months 5. Documented left atrial thrombus on imaging 6. New York Heart Association (NYHA) class III or IV heart failure 7. Hypertrophic obstructive cardiomyopathy 8. Presence of implantable cardioverter defibrillator (ICD) 9. Contraindication to isoproterenol 10. Any other disease or malfunction that would preclude treatment with ablation in the opinion of the investigator 11. Women who are pregnant and/or breast feeding 12. Enrollment in an investigational study evaluating another device, biologic, or drug

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai General Hospital Shanghai Shanghai Municipality

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03963349 on ClinicalTrials.gov ↗ ← All trials in China